Skip to main content

COVID 19 Updates from RheumNow

ICYMI: Our Privilege

Editor's note: This was originally published May 11, 2020 and is being shared again this week in case you missed it. 

ICYMI: COVID-19 and Thrombotic Complications

Editor's note: This article was originally published May 7, 2020 and is being shared again this week in case you missed it. 

ICYMI: The Nine Lives of Hydroxychloroquine (Updated)

Editor's note: This article was originally published May 18, 2020, and is being shared again this week in case you missed it. 

ICYMI: Shutdown and the New Normal

Editor's note: This blog was originally published April 16, 2020, and is being shared again this week in case you missed it. 

ICYMI: Telemedicine Bloopers and Successes

Editor's note: This blog was originally published March 31, 2020 and is being shared again in case you missed it.

ICYMI: Outcomes of Critically-Ill COVID Patients in NYC

Editor's note: This news item was originally published May 21,2020, and is being shared again this week in case you missed it.

COVID's Multisystem Inflammatory Syndrome in Children

Two recent reports further characterize the newly described, Kawasaki-like,  syndrome affecting children with COVID-19 infections.

Tocilizumab May Benefit COVID-19 Pneumonia

A retrospective, observational study published in Lancet Rheumatology has shown that tocilizumab (TCZ) may reduce the risk of death or the need for mechanical ventilation in severe COVID-19 pneumonia.

RheumNow Podcast – Lupus Mortality Declines, But… (6.26.20)

Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Protective Benefit of Colchicine in COVID-19 Infection

Colchicine has been advocated as a potential antiinflammatory intervention in patients with the coronavirus 2 infection and clinical trials have been developed to assess its effect in early COVID-2 infection.  JAMA has published a randomized clinical trial showing that low dose colchici

Reprioritizing your mental health

You’ve heard it said that if you don’t care for yourself, you cannot truly care for others. For many, this can be a hard pill to swallow. Too often we put ourselves last in the line up of importance.

Hydroxychloroquine Fails as Postexposure Prophylaxis for Covid-19

Add this to the list of hydroxychloroquine (HCQ) letdowns in managing COVID-19 treatment or risk - prophylaxis with HCQ fails to prevent COVID-19 infection in those exposed to the SARS-CoV-2 virus. 

Social

"CH COVID-19: Office Hours: COVID-19 Vaccine in Immune-mediated Inflammatory Disease (IMID) Patients" #ACR21 A great thing about @ACRheum's Convergence is being able to listen to conversations about important topics like booster type & timing specifically for #rhum patients https://t.co/horwWeAen7
International Foundation AiArthritis @IFAiArthritis ( View Tweet )
2 years 4 months ago
#ACR21 #SLE #COVID19 Use of Telemedicine for follow-up of SLE in COVID19 Wait times lower for telemedicine Patient satisfaction higher in telemedicine group More hospitalization, higher switch to in person follow up in telemedicine https://t.co/Y21Vki1uDP
Dr. Laura Lewandowski @LauraLewMad11 ( View Tweet )
2 years 4 months ago
Join us now at the #ACR21 #COVID19 community hub to hear Kevin Winthrop and @RADoctor discussing about vaccines in patients with RMDs #ACRAmbassador https://t.co/LivAoLu810
Alessia Alunno @alessia_alunno ( View Tweet )
2 years 4 months ago
COVID in Rheumatologic Disease Patients: Drs. Sparks, Liew, Yazdany and Dao provide an update on data specific to COVID in rheumatologic disease patients. @jeffsparks @drdavidliew @KDAO2011 #ACR21 https://t.co/IzDIpe5IrU https://t.co/6i8C3Grw9q
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
#ACR21 Ab#1445. RTX & #covid19 outcomes ⭐️RTX ass. w/ Upwards arrow COVID hospitalization, ICU admission, and ventilation ▶️We need huge caution in pts that have not been vax'ed before RTX 💉💉 @Rheumnow https://t.co/6UNUVhnBkI https://t.co/vHkQe9fZpI
2 years 4 months ago
@NamrataRheum on outcomes in RA patients on RTX who get COVID-19. ⬆️hospitalisation, ICU, mech ventilation, but not mortality (in this cohort) Abstr#1445 #ACR21 @RheumNow https://t.co/8RcrzTdEb0
Richard Conway @RichardPAConway ( View Tweet )
2 years 4 months ago
#ACR21 Ab#1445. RTX & #covid19 outcomes ⭐️RTX ass. w/ ⬆️ COVID hospitalization, ICU admission, and ventilation ▶️ We need huge caution in pts that have not been vax'ed before RTX 💉💉 @Rheumnow https://t.co/6UNUVh5ZW8 https://t.co/R7jNb066m6
2 years 4 months ago
Yup, another large database shows more #hospitalizations with #RheumatoidArthritis with #rituximab but NOT higher mortality in matched analysis. Abst#1445 #ACR21 @RheumNow https://t.co/9XV8iX10sA
2 years 4 months ago
Are you using less #rituximab in #SLE during #COVID #ACR21 @RheumNow #Lupus hub
2 years 4 months ago
"Baseline and routine EKGS are NOT required for SLE patients just because they are on HCQ!" - Dr. HM Belmont. "The drug has been demonized due to its use in COVID patients. We don't need to hold HCQ for EMR alerts (e.g, with cipro, SSRIs, etc)." Abstr#1743 #ACR21 @rheumnow https://t.co/5Bxavo6dRg
TheDaoIndex @KDAO2011 ( View Tweet )
2 years 4 months ago